Stock Track | 180 Life Sciences (ATNF) Skyrockets 69% Pre-Market on Peter Thiel's 7.5% Stake and Ethereum Plans

Stock Track

Aug 12, 2025

Shares of 180 Life Sciences Corp (ATNF) are soaring in pre-market trading, up a staggering 69.46% following news that billionaire tech investor Peter Thiel has acquired a 7.5% stake in the company. This surge comes as the firm rebrands itself as ETHZilla, positioning itself as an Ethereum-focused corporate treasury vehicle.

The dramatic price movement follows a strong performance on Monday, where the stock already saw an 11% increase at market close. The company's pivot towards blockchain technology and Thiel's involvement appear to be driving investor enthusiasm. 180 Life Sciences recently announced its plans to transform into an Ethereum treasury, a move that has evidently resonated with the market.

Adding to the bullish sentiment, the company disclosed on Monday that it had sold $156 million in senior secured convertible notes due 2028 to an institutional investor. This follows a recent $425 million private placement, with proceeds primarily earmarked for Ethereum purchases, yield-bearing assets, and the company's iGaming operations. The firm also plans to monetize its legacy biotech IP, signaling a significant shift in its business model. With Thiel now holding stakes in two Ethereum treasury companies, including Tom Lee's BitMine Immersion, investors seem to be betting on the potential of corporate Ethereum holdings.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1137115944"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137115944\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137115944?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-12 16:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137115944","market":"sg","top_or_hot":-1,"title":"Stock Track | 180 Life Sciences (ATNF) Skyrockets 69% Pre-Market on Peter Thiel's 7.5% Stake and Ethereum Plans","media":"Stock Track","content":"<p>Shares of 180 Life Sciences Corp (ATNF) are soaring in pre-market trading, up a staggering 69.46% following news that billionaire tech investor Peter Thiel has acquired a 7.5% stake in the company. This surge comes as the firm rebrands itself as ETHZilla, positioning itself as an Ethereum-focused corporate treasury vehicle.</p>\n\n<p>The dramatic price movement follows a strong performance on Monday, where the stock already saw an 11% increase at market close. The company's pivot towards blockchain technology and Thiel's involvement appear to be driving investor enthusiasm. 180 Life Sciences recently announced its plans to transform into an Ethereum treasury, a move that has evidently resonated with the market.</p>\n\n<p>Adding to the bullish sentiment, the company disclosed on Monday that it had sold $156 million in senior secured convertible notes due 2028 to an institutional investor. This follows a recent $425 million private placement, with proceeds primarily earmarked for Ethereum purchases, yield-bearing assets, and the company's iGaming operations. The firm also plans to monetize its legacy biotech IP, signaling a significant shift in its business model. With Thiel now holding stakes in two Ethereum treasury companies, including Tom Lee's BitMine Immersion, investors seem to be betting on the potential of corporate Ethereum holdings.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | 180 Life Sciences (ATNF) Skyrockets 69% Pre-Market on Peter Thiel's 7.5% Stake and Ethereum Plans</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | 180 Life Sciences (ATNF) Skyrockets 69% Pre-Market on Peter Thiel's 7.5% Stake and Ethereum Plans\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-12 16:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of 180 Life Sciences Corp (ATNF) are soaring in pre-market trading, up a staggering 69.46% following news that billionaire tech investor Peter Thiel has acquired a 7.5% stake in the company. This surge comes as the firm rebrands itself as ETHZilla, positioning itself as an Ethereum-focused corporate treasury vehicle.</p>\n\n<p>The dramatic price movement follows a strong performance on Monday, where the stock already saw an 11% increase at market close. The company's pivot towards blockchain technology and Thiel's involvement appear to be driving investor enthusiasm. 180 Life Sciences recently announced its plans to transform into an Ethereum treasury, a move that has evidently resonated with the market.</p>\n\n<p>Adding to the bullish sentiment, the company disclosed on Monday that it had sold $156 million in senior secured convertible notes due 2028 to an institutional investor. This follows a recent $425 million private placement, with proceeds primarily earmarked for Ethereum purchases, yield-bearing assets, and the company's iGaming operations. The firm also plans to monetize its legacy biotech IP, signaling a significant shift in its business model. With Thiel now holding stakes in two Ethereum treasury companies, including Tom Lee's BitMine Immersion, investors seem to be betting on the potential of corporate Ethereum holdings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ETHZ","symbol_name":"ETHZilla Corporation","start_time":0,"source_url":"","article_id":"1137115944","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137115944","pubTimestamp":1754987541,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of 180 Life Sciences Corp (ATNF) are soaring in pre-market trading, up a staggering 69.46% following news that billionaire tech investor Peter Thiel has acquired a 7.5% stake in the company....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ETHZ":"ETHZilla Corporation"},"translate_title":"个股追踪|180 Life Sciences(ATNF)盘前暴涨69%因Peter Thiel持股7.5%及以太币计划","themeId":"0c85ad0f66b7326c7c2cf358c7ed58a1","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ETHZ":1,"ATNF":1},"content_text":"Shares of 180 Life Sciences Corp (ATNF) are soaring in pre-market trading, up a staggering 69.46% following news that billionaire tech investor Peter Thiel has acquired a 7.5% stake in the company. This surge comes as the firm rebrands itself as ETHZilla, positioning itself as an Ethereum-focused corporate treasury vehicle.\nThe dramatic price movement follows a strong performance on Monday, where the stock already saw an 11% increase at market close. The company's pivot towards blockchain technology and Thiel's involvement appear to be driving investor enthusiasm. 180 Life Sciences recently announced its plans to transform into an Ethereum treasury, a move that has evidently resonated with the market.\nAdding to the bullish sentiment, the company disclosed on Monday that it had sold $156 million in senior secured convertible notes due 2028 to an institutional investor. This follows a recent $425 million private placement, with proceeds primarily earmarked for Ethereum purchases, yield-bearing assets, and the company's iGaming operations. The firm also plans to monetize its legacy biotech IP, signaling a significant shift in its business model. With Thiel now holding stakes in two Ethereum treasury companies, including Tom Lee's BitMine Immersion, investors seem to be betting on the potential of corporate Ethereum holdings.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}